Adaptive designs are increasingly used in clinical trials and online experiments to improve participant outcomes by dynamically updating treatment allocation based on accumulating data. However, in practice, experimenters often consider multiple candidate designs, each with distinct trade-offs, while only one can be implemented at a time, leaving benefits and costs of alternative designs unobserved and unquantified. To address this, we propose a novel meta-level adaptive design framework that enables real-time, data-driven evaluation and selection among candidate adaptive designs. Specifically, we define a new class of causal estimands to evaluate adaptive designs, estimate them with Targeted Maximum Likelihood Estimation framework, which yields an asymptotically normal estimator accommodating dependence in adaptive-design data without parametric assumptions, and support online design selection. We further apply this framework to a motivating example where multiple surrogates of a long-term primary outcome are considered for updating randomization probabilities in adaptive experiments. Unlike existing surrogate evaluation methods, our approach comprehensively quantifies the utility of surrogates to accelerate detection of heterogeneous treatment effects, expedite updates to treatment randomization and improve participant outcomes, facilitating dynamic selection among surrogate-guided adaptive designs. Overall, our framework provides a unified tool for evaluating opportunities and costs of various adaptive designs and guiding real-time decision-making in adaptive experiments.
翻译:自适应设计在临床试验和在线实验中日益普及,通过基于累积数据动态更新治疗分配以改善参与者结局。然而,实践中研究者常考虑多个候选设计,各自具有不同的权衡取舍,而每次仅能实施一种设计,导致替代设计的收益与成本无法观测和量化。为解决此问题,我们提出一种新颖的元级自适应设计框架,支持在候选自适应设计间进行实时数据驱动的评估与选择。具体而言,我们定义了一类新的因果估计量以评估自适应设计,采用目标最大似然估计框架进行估计——该框架生成的渐近正态估计量无需参数假设即可适应自适应设计数据中的依赖性,并支持在线设计选择。我们进一步将该框架应用于一个典型案例:在自适应实验中考虑使用长期主要结局的多个替代指标来更新随机化概率。与现有替代指标评估方法不同,本方法全面量化替代指标在加速异质性治疗效果检测、促进治疗随机化更新及改善参与者结局方面的效用,从而支持在替代指标引导的自适应设计间进行动态选择。总体而言,本框架为评估各类自适应设计的机遇与成本、指导自适应实验中的实时决策提供了统一工具。